Label reference · Respiratory & allergy
Incruse Ellipta (Umeclidinium) Aerosol, Powder — label reference
DailyMed · Retrieved 2026-10-13
Incruse Ellipta is listed in DailyMed as aerosol, powder. Active ingredient: umeclidinium bromide. This reference records product facts and version 27; the original prescribing information and PDF are linked.
Reference details
- Brand / product name
- Incruse Ellipta
- Generic product name
- umeclidinium
- Active ingredient
- UMECLIDINIUM BROMIDE
- Dosage form
- AEROSOL, POWDER
- Route
- ORAL
- SPL author / labeler
- GlaxoSmithKline LLC
- SPL version
- 27
- Published on DailyMed
- 2026-05-20
- SPL effective date
- 2023-12-13
- SPL set ID
- dbb64747-1505-49d7-9a33-99dd402e96d3
Product identity
Product name: Incruse Ellipta
Generic name: umeclidinium
Active ingredients: UMECLIDINIUM BROMIDE
Dosage form: AEROSOL, POWDER
Route: ORAL
Label version
DailyMed published this record on 2026-05-20. SPL version: 27. Set ID: dbb64747-1505-49d7-9a33-99dd402e96d3. The SPL effective date is 2023-12-13.
Original prescribing information
Open the original DailyMed label or PDF below for indications, contraindications, dosing instructions, interactions and warnings. This page contains factual product metadata, not the full prescribing information.
Sources and reuse
- Original DailyMed label
- Original label PDF
- Official SPL XML
- Factual label metadata; original label linked
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2026-05-20. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.